Use of CHROMagar medium in the differentiation of Candida species: Is it cost-effective in developing countries?

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 3, 2004, Pages 279-282

  Iyampillai, T ^a   Michael, J S ^a   Mathai, E ^a   Mathews, M S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; DEVELOPING COUNTRY; DEVICE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INDIA; NONHUMAN; STANDARD; TEACHING HOSPITAL;

AGAR; CANDIDA; CHROMOGENIC COMPOUNDS; COST-BENEFIT ANALYSIS; CULTURE MEDIA; DEVELOPING COUNTRIES; DRUG RESISTANCE, FUNGAL; HUMANS; INDIA; MYCOLOGICAL TYPING TECHNIQUES;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; FUNGI;

EID: 2342549285     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349804225003244     Document Type: Article

References (11)

1. Beighton, D., Ludford, R., Clark, D. T., Brailsford, S. R., Pankhurst, C. L., Tinsley, G. F., Fiske, J., Lewis, D., Daly, B., Khaalifa, N., Marren, V. & Lynch, E. (1995). Use of CHROMagar Candida medium for isolation of yeasts from dental samples. Journal of Clinical Microbiology, 33, 3025-3027.
2. Henderson, D. K. (1989). Defining risks for nosocomial candidemia. Archives of Internal Medicine, 149, 2172-2173.
3. Huang, L., Chen, C., Chou, C., Lu, J., Chi, W. & Lee, W. (2001). A comparison of methods for yeast identification including CHROMagar, Vitek system, YBC and traditional biochemical method. Chinese Medical Journal, 64, 568-574.
4. Koehler, A. P., Chu, K.-C., Houang, E. T. S. & Cheng, A. F. B. (1999). Simple, reliable and cost effective yeast identification scheme for the clinical laboratory. Journal of Clinical Microbiology, 37, 422-426.
5. Odds, F. C. & Bernaerts, R. (1994). CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. Journal of Clinical Microbiology, 32, 1923-1929.
6. Mathews, M. S. & Suresh, M. (2001). Mycology. In Manual of Diagnostic Procedures in Medical Microbiology and Immunology/serology, eds Myers, R. M. & Koshi, G. pp. 109-132. Pondicherry, India: All India Press.
7. Mathews, M. S., Samuel, R. P. & Suresh, M. (2001). Emergence of Candida tropicalis as the major cause of fungaemia in India. Mycoses, 44, 278-280.
8. Pfaller, M. A. (1996). Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clinical Infectious Diseases, 22 (Suppl. 2), S89-S94.
9. Pfaller, M. A., Houston, A. & Coffmann, S. (1996). Application of CHROMagar for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida (Torulopsis) glabrata. Journal of Clinical Microbiology, 34, 58-61.
10. Sullivan, D. & Coleman, D. (1998). Candida dubliniensis - characteristics and identification. Journal of Clinical Microbiology, 36, 329-334.
11. Willinger, B. & Manafi, M. (1999). Evaluation of CHROMagar Candida for screening of clinical specimens for Candida species. Mycoses, 42, 61-65.